Informed Patients Are More Likely to Choose Palliative Care

Laura M. Perry, BS and Michael Hoerger, PhD, MSCR | July 03, 2017
Project EMPOWER demonstrates the importance of psychoeducation in healthcare decision making, especially regarding treatment decisions that are often driven by strong emotions and misconceptions, such as deciding whether to pursue palliative care. However, this research only targeted individual preferences, and future translational research is necessary to clarify whether psychoeducational interventions can ultimately improve quality of life by increasing use of palliative care services.

It would also be worthwhile to explore alternative methods of disseminating information about palliative care to patients (eg, mobile apps and other forms of technology). Another direction that future research should address is the role of the therapeutic relationship and whether direct communication between clinicians and patients has an impact on palliative care use.

Nevertheless, our research provides a strong case that, across demographic and clinical populations, informed patients are less wary of palliative care and more inclined to take advantage of the favorable effects that palliative care services can offer for patient-centered outcomes.

References

  1. NCI Dictionary of Cancer Terms. National Cancer Institute website. www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=269448. Posted May 15, 2015. Accessed May 10, 2017.
  2. Temel JS, Greer JA, El-Jawahri A, et al. Effects of early integrated palliative care in patients with lung and gi cancer: a randomized clinical trial. J Clin Oncol. 2017;35(8):834-841. doi: 10.1200/JCO.2016.70.5046.
  3. Bakitas MA, Tosteson TD, Li Z, et al. Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol. 2015;33(13):1438-1445. doi: 10.1200/JCO.2014.58.6362.
  4. Zimmermann C, Swami N, Krzyzanowska M, et al. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet. 2014;383(9930):1721-1730. doi: 10.1016/S0140-6736(13)62416-2.
  5. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733-742. doi: 10.1056/NEJMoa1000678.
  6. Hui D, Elsayem A, De la Cruz M, et al. Availability and integration of palliative care at US cancer centers. JAMA. 2010;303(11):1054-1061. doi: 10.1001/jama.2010.258.
  7. Bailey FA, Williams BR, Woodby LL, et al. Intervention to improve care at life’s end in inpatient settings: the BEACON trial. J Gen Intern Med. 2014;29(6):836-843. doi: 10.1007/s11606-013-2724-6.
  8. Institute of Medicine (IOM). Dying in America: Improving quality and honoring individual preferences near the end of life. Washington, DC: National Academies Press; 2014. www.nationalacademies.org/hmd/Reports/2014/Dying-In-America-Improving-Quality-and-Honoring-Individual-Preferences-Near-the-End-of-Life.aspx.
  9. Lo B, Quill, T., Tulsky, J; ACP-ASIM End-of-Life Care Consensus Panel. Discussing palliative care with patients. Ann Intern Med. 1999;130(9):744-749. DOI: 10.7326/0003-4819-130-9-199905040-00015.
  10. Hoerger M, Perry LM, Gramling R, Epstein RM, Duberstein PR. Does educating patients about the Early Palliative Care Study increase preferences for outpatient palliative cancer care? Findings from Project EMPOWER. Health Psychol. 2017;36(6):538-548. doi: 10.1037/hea0000489.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Advances in™ Precision Medicine: The Evolving Role of Genomics and Proteomics in Cancer Treatment: Current and Emerging Roles for Molecular Testing Technologies: Real-World Application into PracticeAug 29, 20171.5
Community Practice Connections™: Oncogenic Tumor Board in NSCLC: Targeting Driver Mutations to Maximize Therapeutic OutcomesAug 31, 20171.5
Publication Bottom Border
Border Publication